S&P 500   3,453.49 (+0.52%)
DOW   28,363.66 (+0.54%)
QQQ   284.18 (+0.00%)
AAPL   115.75 (-0.96%)
MSFT   214.89 (+0.04%)
FB   278.12 (-0.22%)
GOOGL   1,606.66 (+1.30%)
AMZN   3,176.40 (-0.27%)
TSLA   425.79 (+0.75%)
NVDA   534.44 (-1.21%)
BABA   306.28 (-0.55%)
CGC   20.30 (+4.16%)
GE   7.72 (+5.46%)
MU   54.38 (+2.01%)
AMD   79.42 (+0.28%)
T   28.28 (+5.84%)
F   8.21 (+4.59%)
ACB   4.85 (+0.00%)
GILD   60.67 (+0.76%)
NFLX   485.23 (-0.78%)
BA   169.07 (+3.18%)
NIO   27.38 (-1.72%)
BAC   24.87 (+3.41%)
S&P 500   3,453.49 (+0.52%)
DOW   28,363.66 (+0.54%)
QQQ   284.18 (+0.00%)
AAPL   115.75 (-0.96%)
MSFT   214.89 (+0.04%)
FB   278.12 (-0.22%)
GOOGL   1,606.66 (+1.30%)
AMZN   3,176.40 (-0.27%)
TSLA   425.79 (+0.75%)
NVDA   534.44 (-1.21%)
BABA   306.28 (-0.55%)
CGC   20.30 (+4.16%)
GE   7.72 (+5.46%)
MU   54.38 (+2.01%)
AMD   79.42 (+0.28%)
T   28.28 (+5.84%)
F   8.21 (+4.59%)
ACB   4.85 (+0.00%)
GILD   60.67 (+0.76%)
NFLX   485.23 (-0.78%)
BA   169.07 (+3.18%)
NIO   27.38 (-1.72%)
BAC   24.87 (+3.41%)
S&P 500   3,453.49 (+0.52%)
DOW   28,363.66 (+0.54%)
QQQ   284.18 (+0.00%)
AAPL   115.75 (-0.96%)
MSFT   214.89 (+0.04%)
FB   278.12 (-0.22%)
GOOGL   1,606.66 (+1.30%)
AMZN   3,176.40 (-0.27%)
TSLA   425.79 (+0.75%)
NVDA   534.44 (-1.21%)
BABA   306.28 (-0.55%)
CGC   20.30 (+4.16%)
GE   7.72 (+5.46%)
MU   54.38 (+2.01%)
AMD   79.42 (+0.28%)
T   28.28 (+5.84%)
F   8.21 (+4.59%)
ACB   4.85 (+0.00%)
GILD   60.67 (+0.76%)
NFLX   485.23 (-0.78%)
BA   169.07 (+3.18%)
NIO   27.38 (-1.72%)
BAC   24.87 (+3.41%)
S&P 500   3,453.49 (+0.52%)
DOW   28,363.66 (+0.54%)
QQQ   284.18 (+0.00%)
AAPL   115.75 (-0.96%)
MSFT   214.89 (+0.04%)
FB   278.12 (-0.22%)
GOOGL   1,606.66 (+1.30%)
AMZN   3,176.40 (-0.27%)
TSLA   425.79 (+0.75%)
NVDA   534.44 (-1.21%)
BABA   306.28 (-0.55%)
CGC   20.30 (+4.16%)
GE   7.72 (+5.46%)
MU   54.38 (+2.01%)
AMD   79.42 (+0.28%)
T   28.28 (+5.84%)
F   8.21 (+4.59%)
ACB   4.85 (+0.00%)
GILD   60.67 (+0.76%)
NFLX   485.23 (-0.78%)
BA   169.07 (+3.18%)
NIO   27.38 (-1.72%)
BAC   24.87 (+3.41%)
Log in
NYSEARCA:IDNA

iShares Genomics Immunology and Healthcare ETF Stock Forecast, Price & News

$39.65
+0.50 (+1.28 %)
(As of 10/22/2020 04:15 PM ET)
Add
Today's Range
$39.28
Now: $39.65
$39.83
50-Day Range
$35.37
MA: $39.00
$42.11
52-Week Range
$22.32
Now: $39.65
$42.38
Volume24,096 shs
Average Volume53,022 shs
Market Capitalization$166.53 million
P/E RatioN/A
Dividend Yield0.83%
BetaN/A

Geographic Exposure of IDNA

Currency Exposure of IDNA

Sector Exposure of IDNA

Industry Exposure of IDNA

Basic Details

Issuer iShares
Fund NameiShares Genomics Immunology and Healthcare ETF
Tax ClassificationRegulated Investment Company
SymbolNYSEARCA:IDNA
Inception Date6/11/2019
Fund ManagerRachel Aguirre, Jennifer Hsui, Alan Mason, Greg Savage, Amy Whitelaw
WebN/A
PhoneN/A

Fund Focus

Asset ClassEquity
BenchmarkNYSE FactSet Global Genomics and Immuno Biopharma Index
CategoryStrategy
FocusTheme
Development LevelBlended Development
RegionGlobal

Fund Statistics

Assets Under Management$160.97 million
Average Daily Volume$0.00
Discount/Premium0.00%

ETF Expenses

Management Fee0.47%
Other Expenses0.00%
Total Expenses0.47%
Fee Waiver0.00%
Net Expenses0.47%

Administrator, Advisor and Custodian

AdministratorState Street Bank and Trust Company
AdvisorBlackRock Fund Advisors
CustodianState Street Bank and Trust Company
DistributorBlackRock Investments, LLC
Transfer AgentState Street Bank and Trust Company
Trustee
Lead Market Maker
$39.65
+0.50 (+1.28 %)
(As of 10/22/2020 04:15 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive IDNA News and Ratings via Email

Sign-up to receive the latest news and ratings for IDNA and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) Frequently Asked Questions

How has iShares Genomics Immunology and Healthcare ETF's stock price been impacted by Coronavirus (COVID-19)?

iShares Genomics Immunology and Healthcare ETF's stock was trading at $26.77 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, IDNA shares have increased by 48.1% and is now trading at $39.65.
View which stocks have been most impacted by COVID-19
.

How often does iShares Genomics Immunology and Healthcare ETF pay dividends? What is the dividend yield for iShares Genomics Immunology and Healthcare ETF?

iShares Genomics Immunology and Healthcare ETF announced a -- dividend on Monday, December 16th. Shareholders of record on Tuesday, December 17th will be given a dividend of $0.2402 per share on Friday, December 20th. The ex-dividend date of this dividend is Monday, December 16th.
View iShares Genomics Immunology and Healthcare ETF's dividend history
.

What other stocks do shareholders of iShares Genomics Immunology and Healthcare ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other iShares Genomics Immunology and Healthcare ETF investors own include Pfizer (PFE), Gilead Sciences (GILD), Intel (INTC), AbbVie (ABBV), Inovio Pharmaceuticals (INO), Novavax (NVAX), Canadian Natural Resources (CNQ), QUALCOMM (QCOM), SPDR S&P Biotech ETF (XBI) and Bristol-Myers Squibb (BMY).

What is iShares Genomics Immunology and Healthcare ETF's stock symbol?

iShares Genomics Immunology and Healthcare ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "IDNA."

How do I buy shares of iShares Genomics Immunology and Healthcare ETF?

Shares of IDNA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is iShares Genomics Immunology and Healthcare ETF's stock price today?

One share of IDNA stock can currently be purchased for approximately $39.65.

How big of a company is iShares Genomics Immunology and Healthcare ETF?

iShares Genomics Immunology and Healthcare ETF has a market capitalization of $166.53 million.

This page was last updated on 10/22/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.